Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03WPI
|
||||
Former ID |
DIB001826
|
||||
Drug Name |
NC-190
|
||||
Synonyms |
NCU-190Na
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 2 | [544763] | ||
Company |
Taisho Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H21N4NaO5
|
||||
Canonical SMILES |
c12c(c(c(c3c1cccc3)O)C(=O)NCCN(C)C)nc1c(n2)cc(c(c1)C(=O<br />)[O-])OC.[Na+]
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA topoisomerase II | Target Info | Modulator | [526888] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.